<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Miao J</submitter><funding>Guangzhou Science and Technology Planning Project</funding><funding>National Natural Science Foundation of China</funding><funding>Natural Science Foundation of Guangdong Province</funding><pagination>2885-2899</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7957162</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(6)</volume><pubmed_abstract>Inflammation is a biological process that exists in a large number of diseases. If the magnitude or duration of inflammation becomes uncontrolled, inflammation may cause pathological damage to the host. HMGB1 and NF-κB have been shown to play pivotal roles in inflammation-related diseases. New drugs aimed at inhibiting HMGB1 expression have become a key research focus. In the present study, we showed that paeonol (Pae), the main active component of Paeonia suffruticosa, decreases the expression of inflammatory cytokines and inhibits the translocation of HMGB1 induced by lipopolysaccharide (LPS). By constructing HMGB1-overexpressing (HMGB1&lt;sup>+&lt;/sup> ) and HMGB1-mutant (HMGB1&lt;sup>m&lt;/sup> ) RAW264.7 cells, we found that the nuclear HMGB1 could induce an LPS-tolerant state in RAW264.7 cells </pubmed_abstract><journal>Journal of cellular and molecular medicine</journal><pubmed_title>Paeonol attenuates inflammation by confining HMGB1 to the nucleus.</pubmed_title><pmcid>PMC7957162</pmcid><funding_grant_id>81873162</funding_grant_id><funding_grant_id>2018040 10113</funding_grant_id><funding_grant_id>2018B030 311014</funding_grant_id><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Ye P</pubmed_authors><pubmed_authors>Ye S</pubmed_authors><pubmed_authors>You A</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Zhong J</pubmed_authors><pubmed_authors>Miao J</pubmed_authors><pubmed_authors>Lan J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Paeonol attenuates inflammation by confining HMGB1 to the nucleus.</name><description>Inflammation is a biological process that exists in a large number of diseases. If the magnitude or duration of inflammation becomes uncontrolled, inflammation may cause pathological damage to the host. HMGB1 and NF-κB have been shown to play pivotal roles in inflammation-related diseases. New drugs aimed at inhibiting HMGB1 expression have become a key research focus. In the present study, we showed that paeonol (Pae), the main active component of Paeonia suffruticosa, decreases the expression of inflammatory cytokines and inhibits the translocation of HMGB1 induced by lipopolysaccharide (LPS). By constructing HMGB1-overexpressing (HMGB1&lt;sup>+&lt;/sup> ) and HMGB1-mutant (HMGB1&lt;sup>m&lt;/sup> ) RAW264.7 cells, we found that the nuclear HMGB1 could induce an LPS-tolerant state in RAW264.7 cells </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2025-04-22T10:45:09.523Z</modification><creation>2025-04-05T23:42:14.675Z</creation></dates><accession>S-EPMC7957162</accession><cross_references><pubmed>33534963</pubmed><doi>10.1111/jcmm.16319</doi></cross_references></HashMap>